UFP Technologies UFPT Number of Vested and Expected to Vest Options

Number of Vested and Expected to Vest Options at other companies

Medline, Inc. MDLN

——

STERISSTE

——

Other financials

Income statement

See full

Revenue$154.2M+4.1%

Gross profit$44.4M+5.2%

Operating income$23.4M+1.0%

Net income$17.5M+1.8%

EPS (diluted)$2.24+1.4%

Balance sheet

See full

Cash & equivalents$20.0M+42.4%

Total debt$156.1M-21.4%

Total equity$438.9M+21.7%

Total assets$674.7M+5.0%

Cash flow

See full

Operating cash flow$3.2M-76.8%

CapEx$2.9M+3.1%

Free cash flow$22.5M+151%

Valuation

See full

Market cap$1.88B-3.6%

Profitability

See full

Gross margin28.4%-0.6pp

Operating margin15.2%-0.9pp

Net margin11.3%-0.3pp

FCF margin12.3%+2.0pp

Returns & leverage

See full

Return on equity17.2%-2.2pp

Debt / equity0.4×-0.2×

Current ratio2.9×+0.3×

Where this comes from

Reported directly by UFP Technologies in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue.

The official record: UFP Technologies’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about UFP Technologies's number of vested and expected to vest options.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is UFP Technologies's number of vested and expected to vest options?: UFP Technologies (UFPT) reported number of vested and expected to vest options of $7.19M in Q1 2026.